Related Experiment Video
Updated: Sep 2, 2025
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
RNA 5-methylcytosine status is associated with DNMT2/TRDMT1 nuclear localization in osteosarcoma cell lines
Gabriela Betlej1, Tomasz Ząbek2, Anna Lewińska3
1Institute of Physical Culture Studies, College of Medical Sciences, University of Rzeszow, Rzeszow 35-310, Poland.
Abstract:
Osteosarcoma (OS) is a pediatric malignant bone tumor with unsatisfying improvements in survival rates due to limited understanding of OS biology and potentially druggable targets. The present study aims to better characterize osteosarcoma U-2 OS, SaOS-2, and MG-63 cell lines that are commonly used as in vitro models of OS. We focused on evaluating the differences in cell death pathways, redox equilibrium, the activity of proliferation-related signaling pathways, DNA damage response, telomere maintenance, DNMT2/TRDMT1-based responses and RNA 5-methylcytosine status. SaOS-2 cells were characterized by higher levels of superoxide and nitric oxide that promoted AKT and ERK1/2 activation thus modulating cell death pathways. OS cell lines also differed in the levels and localization of DNA repair regulator DNMT2/TRDMT1. SaOS-2 cells possessed the lowest levels of total, cytoplasmic and nuclear DNMT2/TRDMT1, whereas in MG-63 cells, the highest levels of nuclear DNMT2/TRDMT1 were associated with the most pronounced status of RNA 5-methylcytosine. In silico analysis revealed potential phosphorylation sites at DNMT2/TRDMT1 that may be related to the regulation of DNMT2/TRDMT1 localization. We postulate that redox homeostasis, proliferation-related pathways and DNMT2/TRDMT1-based effects can be modulated as a part of anti-osteosarcoma strategy reflecting diverse phenotypic features of OS cells.
Insights
This study characterizes osteosarcoma cell lines, revealing distinct differences in cell death, redox balance, and DNA repair mechanisms. Targeting these pathways offers potential strategies against osteosarcoma (OS).
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Osteosarcoma (OS) survival rates remain poor due to limited understanding of its biology and therapeutic targets.
- Existing in vitro models like U-2 OS, SaOS-2, and MG-63 cell lines require deeper characterization.
Purpose of the Study:
- To comprehensively analyze and compare key biological differences between commonly used OS cell lines.
- To investigate variations in cell death, redox status, proliferation pathways, DNA damage response, telomere maintenance, and RNA methylation.
Main Methods:
- Comparative analysis of U-2 OS, SaOS-2, and MG-63 cell lines.
- Evaluation of cell death pathways, redox equilibrium (superoxide, nitric oxide), and signaling pathway activity (AKT, ERK1/2).
- Assessment of DNA damage response, telomere maintenance, DNMT2/TRDMT1 levels/localization, and RNA 5-methylcytosine status; in silico analysis of DNMT2/TRDMT1.
Main Results:
- SaOS-2 cells exhibited higher superoxide and nitric oxide levels, activating AKT and ERK1/2, influencing cell death.
- Significant differences in DNMT2/TRDMT1 levels and localization were observed across cell lines.
- MG-63 cells showed high nuclear DNMT2/TRDMT1 correlating with increased RNA 5-methylcytosine; in silico analysis suggested phosphorylation sites regulating DNMT2/TRDMT1 localization.
Conclusions:
- Osteosarcoma cell lines display diverse phenotypic features impacting their biology.
- Modulating redox homeostasis, proliferation pathways, and DNMT2/TRDMT1-based responses presents a potential anti-osteosarcoma strategy.
More Related Videos
12:18LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
06:07Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Related Concept Videos
01:53RNA Stability
02:55The Nucleolus
02:22Regulated mRNA Transport